DE69327553D1 - E.Coli P-Fimbriae als immunogener Träger gegen GnRH - Google Patents

E.Coli P-Fimbriae als immunogener Träger gegen GnRH

Info

Publication number
DE69327553D1
DE69327553D1 DE69327553T DE69327553T DE69327553D1 DE 69327553 D1 DE69327553 D1 DE 69327553D1 DE 69327553 T DE69327553 T DE 69327553T DE 69327553 T DE69327553 T DE 69327553T DE 69327553 D1 DE69327553 D1 DE 69327553D1
Authority
DE
Germany
Prior art keywords
coli
fimbriae
immunogenic carrier
against gnrh
carrier against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69327553T
Other languages
English (en)
Other versions
DE69327553T2 (de
Inventor
Der Zee Anna Van
Die Irma Marianne Van
Willem Pieter Martin Hoekstra
Josephus Theodorus Gielen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of DE69327553D1 publication Critical patent/DE69327553D1/de
Application granted granted Critical
Publication of DE69327553T2 publication Critical patent/DE69327553T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Gyroscopes (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69327553T 1992-06-18 1993-06-15 E.Coli P-Fimbriae als immunogener Träger gegen GnRH Expired - Fee Related DE69327553T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92201775 1992-06-18

Publications (2)

Publication Number Publication Date
DE69327553D1 true DE69327553D1 (de) 2000-02-17
DE69327553T2 DE69327553T2 (de) 2000-08-10

Family

ID=8210697

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69327553T Expired - Fee Related DE69327553T2 (de) 1992-06-18 1993-06-15 E.Coli P-Fimbriae als immunogener Träger gegen GnRH

Country Status (18)

Country Link
US (2) US5684145A (de)
EP (1) EP0578293B1 (de)
JP (1) JPH0656696A (de)
KR (1) KR100293025B1 (de)
AT (1) ATE188737T1 (de)
AU (1) AU667715B2 (de)
BR (1) BR9302408A (de)
CA (1) CA2098533C (de)
DE (1) DE69327553T2 (de)
DK (1) DK0578293T3 (de)
ES (1) ES2142848T3 (de)
GR (1) GR3033086T3 (de)
HU (1) HU217096B (de)
MX (1) MX303646A (de)
NZ (1) NZ247907A (de)
PT (1) PT578293E (de)
TW (1) TW240232B (de)
ZA (1) ZA934199B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8826116D0 (en) * 1988-11-08 1988-12-14 Danbiosyst Ltd Adhesive drug delivery composition
EP0596959B1 (de) * 1991-07-26 2000-03-29 Commonwealth Scientific And Industrial Research Organisation System der bereitstellung eines impfstoffes auf peptidbasis, das sein eigenes adjuvans bildet, und seine herstellung
US5759551A (en) * 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
US5688506A (en) * 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
AU1532795A (en) * 1994-01-27 1995-08-15 Gx Biosystems A/S Receptor specific bacterial adhesins and their use
US6635740B1 (en) * 1997-03-27 2003-10-21 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Ligand/lytic peptide compositions and methods of use
AUPO776897A0 (en) * 1997-07-09 1997-07-31 Csl Limited A method of achieving production gains in livestock and agents useful for same
US6013770A (en) * 1997-07-21 2000-01-11 Washington State University Chimeric contraceptive vaccines
US6258782B1 (en) * 1998-05-20 2001-07-10 Trimeris, Inc. Hybrid polypeptides with enhanced pharmacokinetic properties
US6656906B1 (en) * 1998-05-20 2003-12-02 Trimeris, Inc. Hybrid polypeptides with enhanced pharmacokinetic properties
AUPP807399A0 (en) 1999-01-08 1999-02-04 Csl Limited Improved immunogenic lhrh composition and methods relating thereto
DE60017211T2 (de) * 1999-02-17 2005-06-02 Pfizer Products Inc., Groton Fusionsproteine mit Trägern welche eine doppelte Immunantwort induzieren
WO2001085208A2 (en) * 2000-05-05 2001-11-15 Cytos Biotechnology Ag Molecular antigen arrays and vaccines
US6783761B2 (en) 2000-05-05 2004-08-31 Aphton Corporation Chimeric peptide immunogens
US7320793B2 (en) 2001-01-19 2008-01-22 Cytos Biotechnology Ag Molecular antigen array
AU2002362696B2 (en) * 2001-10-05 2008-05-29 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
WO2004016282A1 (en) 2002-07-19 2004-02-26 Cytos Biotechnology Ag Vaccine compositions containing amyloid beta1-6 antigen arrays
US7537767B2 (en) 2003-03-26 2009-05-26 Cytis Biotechnology Ag Melan-A- carrier conjugates
WO2004084940A1 (en) 2003-03-26 2004-10-07 Cytos Biotechnology Ag Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use
GB0424563D0 (en) 2004-11-05 2004-12-08 Novartis Ag Organic compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL78775A (en) * 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines
NZ220932A (en) * 1986-07-03 1990-05-28 Victoria State Composition comprising an antigenic substance, such as lhrh, conjugated to at least two different carriers and method of immunological castration and spaying
DE3783425T2 (de) * 1986-10-13 1993-05-13 Solvay Mikroorganismen, die fremdproteinenthaltende pili tragen, isolierte pili, verfahren zur ausscheidung von proteinen in verwendung dieser pili und deren nutzen.
AU616662B2 (en) * 1987-04-27 1991-11-07 Commonwealth Scientific And Industrial Research Organisation Peptide production by protein engineering
DE3871489D1 (de) * 1987-10-26 1992-07-02 Akzo Nv Impfstoff gegen e.coli-blutvergiftung bei gefluegel.
US5036047A (en) * 1988-09-29 1991-07-30 Pitman-Moore, Inc. Method and composition for preventing conception
GB8826116D0 (en) * 1988-11-08 1988-12-14 Danbiosyst Ltd Adhesive drug delivery composition
GB2228262B (en) * 1989-01-25 1992-10-07 Nat Inst Immunology Antigenic derivative of gnrh
NL8900726A (nl) * 1989-03-23 1990-10-16 Stichting Centr Diergeneeskund Peptide, immunogene samenstelling en vaccin- of geneesmiddelpreparaat; werkwijze voor het immuniseren van een zoogdier tegen lhrh, en werkwijze voor het verbeteren van de vleeskwaliteit van varkens.

Also Published As

Publication number Publication date
ATE188737T1 (de) 2000-01-15
JPH0656696A (ja) 1994-03-01
KR100293025B1 (ko) 2001-09-17
HUT68554A (en) 1995-06-28
CA2098533A1 (en) 1993-12-19
NZ247907A (en) 1994-12-22
BR9302408A (pt) 1994-01-11
DE69327553T2 (de) 2000-08-10
AU667715B2 (en) 1996-04-04
ES2142848T3 (es) 2000-05-01
HU9301764D0 (en) 1993-10-28
MX303646A (es) 1994-05-31
EP0578293A1 (de) 1994-01-12
GR3033086T3 (en) 2000-08-31
PT578293E (pt) 2000-06-30
KR940000115A (ko) 1994-01-03
AU4134393A (en) 1993-12-23
US6019983A (en) 2000-02-01
HU217096B (hu) 1999-11-29
EP0578293B1 (de) 2000-01-12
DK0578293T3 (da) 2000-06-26
TW240232B (de) 1995-02-11
ZA934199B (en) 1994-01-10
CA2098533C (en) 2005-08-16
US5684145A (en) 1997-11-04

Similar Documents

Publication Publication Date Title
ATE188737T1 (de) E.coli p-fimbriae als immunogener träger gegen gnrh
AU1471797A (en) Hybrid protein between CS from plasmodium and HBsAG
DE69419966D1 (de) Impstoff gegen Streptococcus suis-Infektion
AU2521792A (en) Chicken anaemia agent vaccine
GEP20053446B (en) Adjuvant Combination Formulations
DK665688A (da) Polypeptid
MX9300883A (es) Polipeptidos de vacuna.
NL300336I2 (nl) Vaccin tegen de bof dat een jeryl-lynn virusstam bevat
FI932759A0 (fi) Anvaendningen av IL-4 foer oekning av pao vacciners immunogener verkande immunreaktioner
EP0529019A4 (en) Nematode vaccine
IT1217314B (it) Nonapeptide sintetico ad attivita'adiuvante capace di potenziare in vivo la risposta anticorporale
ATE136586T1 (de) Protektive plasmodium falciparum hybridproteine, die teilsequenzen der malaria-antigene hrpii und serp enthalten
ATE99955T1 (de) Als anti-malaria-impfstoff verwendbares immunologisch aktives peptidkonjugat ppd-(nanp)n.
EP0693936A4 (de) KLONIERTES AUSSENMEMBRANPROTEIN VON -i(LEPTOSPIRA)
RU93043610A (ru) Фармацевтическая композиция для усиления первичной иммуно-реакции у млекопитающих, способ усиления первичной иммуно-реакции и применение интерлейкина-4 для усиления первичной иммуно-реакции у млекопитающих, набор лекарственных средств

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee